Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.6K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

3.8K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

1.6K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.6K
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

1.7K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic Silencing of Tmprss6 Reduces Iron-Induced Inflammation and Prolongs Survival in MDS Mice.

American journal of hematology·2026
Same author

Neutrophil extracellular traps induced by activated platelets as a cause of neutrophil-platelet aggregation in β-thalassaemia/haemoglobin E patients.

British journal of haematology·2026
Same author

Establishment of a human induced pluripotent stem cell line MUi036-A from healthy male CD34<sup>+</sup> hematopoietic stem/progenitor cells.

Stem cell research·2026
Same author

Phosphorylated filamin-A at serine 1459 from plasma-derived small extracellular vesicles as a promising biomarker for high-risk adenoma and colorectal cancer.

Scientific reports·2026
Same author

Small vesicles, big potential: A review of innovative exosome delivery and molecular mechanisms in preclinical myocardial infarction models.

Animal models and experimental medicine·2026
Same author

In vitro characterization and angiogenic potential of quality-and-quantity mononuclear cell-derived extracellular vesicles.

JVS-vascular science·2026

Related Experiment Video

Updated: Feb 6, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

5.0K

Microparticles from β-thalassaemia/HbE patients induce endothelial cell dysfunction.

Wasinee Kheansaard1,2, Kunwadee Phongpao1,2, Kittiphong Paiboonsukwong1

  • 1Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.

Scientific Reports
|August 31, 2018
PubMed
Summary

Microparticles (MPs) from beta-thalassemia/HbE patients activate endothelial cells, increasing thrombosis risk. This effect is more pronounced in splenectomised patients, highlighting MPs

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-&#946; Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

11.8K
Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
08:04

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells

Published on: November 19, 2020

7.1K

Related Experiment Videos

Last Updated: Feb 6, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

5.0K
Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-&#946; Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

11.8K
Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
08:04

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells

Published on: November 19, 2020

7.1K

Area of Science:

  • Hematology
  • Vascular Biology
  • Thrombosis Research

Background:

  • Beta-thalassemia/HbE patients frequently experience thromboembolic complications, especially after splenectomy.
  • Endothelial cell activation and dysfunction are implicated in beta-thalassemia pathogenesis.
  • Microparticles (MPs) are linked to thrombosis and endothelial dysfunction in various diseases, including beta-thalassemia.

Purpose of the Study:

  • To investigate the impact of circulating microparticles (MPs) from beta-thalassemia/HbE patients on endothelial cell function.
  • To determine if MPs mediate thrombus formation by affecting endothelial cells.
  • To compare the effects of MPs from splenectomised versus non-splenectomised beta-thalassemia/HbE patients.

Main Methods:

  • Isolated circulating MPs from beta-thalassemia/HbE patients (splenectomised and non-splenectomised) and normal subjects.
  • Treated human umbilical vein endothelial cells (HUVECs) with these MPs.
  • Assessed endothelial cell activation markers (tissue factor, IL-6, IL-8, ICAM-1, VCAM-1, E-selectin) and monocyte-HUVEC adhesion.

Main Results:

  • MPs from beta-thalassemia/HbE patients directly induced expression of key endothelial activation markers in HUVECs.
  • MPs from splenectomised beta-thalassemia/HbE patients caused significantly higher endothelial cell activation compared to non-splenectomised patients or normal subjects.
  • MP-induced endothelial cell activation led to increased monocyte-endothelial cell adhesion, with the highest adhesion observed with MPs from splenectomised patients.

Conclusions:

  • Circulating MPs play a significant role in promoting thrombosis and vascular dysfunction in beta-thalassemia/HbE.
  • Splenectomy exacerbates the pro-thrombotic effects of MPs in beta-thalassemia/HbE patients.
  • MPs represent a key mechanism linking beta-thalassemia/HbE to increased thrombotic risk, particularly in splenectomised individuals.